4//SEC Filing
Discordia Robert Paul 4
Accession 0001209191-20-017400
CIK 0001595097other
Filed
Mar 8, 8:00 PM ET
Accepted
Mar 9, 5:24 PM ET
Size
5.6 KB
Accession
0001209191-20-017400
Insider Transaction Report
Form 4
Discordia Robert Paul
Chief Operating Officer
Transactions
- Award
Stock Option(right to buy)
2020-03-06+226,000→ 226,000 totalExercise: $4.53Exp: 2030-03-06→ Common Stock (226,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on March 6, 2021, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on April 6, 2021.
Documents
Issuer
Corbus Pharmaceuticals Holdings, Inc.
CIK 0001595097
Entity typeother
Related Parties
1- filerCIK 0001784644
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 8:00 PM ET
- Accepted
- Mar 9, 5:24 PM ET
- Size
- 5.6 KB